Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling

Clinical Chemistry

Volumn 60, Issue 2, 2014, Pages 399-412

  Kamlage, Beate ^a   Maldonado, Sandra González ^a   Bethan, Bianca ^a   Peter, Erik ^a   Schmitz, Oliver ^a   Liebenberg, Volker ^a   Schatz, Philipp ^a  

^a Metanomics GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; CARBOHYDRATE DERIVATIVE; CATECHOLAMINE DERIVATIVE; HEMOGLOBIN; ICOSANOID; SEROTONIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; DRUG TARGETING; ENERGY METABOLISM; FEMALE; FRACTIONATION; HEMOLYSIS; HUMAN; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; METABOLITE; METABOLOME; METABOLOMICS; PLASMA; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; TEMPERATURE; TRANSCRIPTOMICS; YOUNG ADULT; ADOLESCENT; BLOOD; BLOOD SAMPLING; METABOLISM; PROCEDURES; STANDARDS; TIME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD; BLOOD SPECIMEN COLLECTION; FEMALE; HUMANS; MALE; METABOLOME; METABOLOMICS; PLASMA; QUALITY CONTROL; TIME FACTORS; YOUNG ADULT;

EID: 84893490530     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.211979     Document Type: Article

References (39)

1. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113-26.
2. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 2006;44:750-9.
3. Vaught J, Rogers J, Myers K, Lim MD, Lockhart N, Moore H, et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011;2011:1-7.
4. Pazzagli M, Malentacchi F, Simi L, Orlando C, Wyrich R, Gunther K, et al. SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. Methods 2013;59:20-31.
5. Betsou F, Gunter E, Clements J, De Souza Y, Goddard KA, Guadagni F, et al. Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science working group. J Mol Diagn 2013;15:3-16.
6. Gunther K, Malentacchi F, Verderio P, Pizzamiglio S, Ciniselli CM, Tichopad A, et al. Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. Clin Chim Acta 2012;413:779-86.
7. Rai AJ, Vitzthum F. Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Rev Proteomics 2006;3:409-26.
8. Guendisch S, Hauck S, Sarioglu H, Schott C, Viertler C, Kap M, et al. Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase. J Proteome Res 2012;11:5748-62.
9. Aguilar-Mahecha A, Kuzyk MA, Domanski D, Borchers CH, Basik M. The effect of pre-analytical variability on the measurement of MRM-MS-based mid-to high-abundance plasma protein biomarkers and a panel of cytokines. PLoS One 2012;7:e38290.
10. Schlotterbeck G, Ross A, Dieterle F, Senn H. Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. Pharmacogenomics 2006;7:1055-75.
11. Putri SP, Nakayama Y, Matsuda F, Uchikata T, Kobayashi S, Matsubara A, Fukusaki E. Current metabolomics: practical applications. J Biosci Bioeng 2013;115:579-89.
12. Yin P, Peter A, Franken H, Zhao X, Neukamm SS, Rosenbaum L, et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem 2013;59:833-45.
13. Yang W, Chen Y, Xi C, Zhang R, Song Y, Zhan Q, et al. Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on reliability of potential biomarkers. Anal Chem 2013;85:2606-10.
14. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 2011;49:231-43.
15. Fliniaux O, Gaillard G, Lion A, Cailleu D, Mesnard F, Betsou F. Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks. J Biomol NMR 2011;51:457-65.
16. Barri T, Dragsted LO. UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal Chim Acta 2013;768:118-28.
17. Tapernon K, Zander R, Niehoff D, Sibrowski W. Quality control of hemolysis rate of erythrocyte concentrates: a proficiency test for determination of free hemoglobin [in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 2001;36(Suppl 1):S45-50.
18. Van Ravenzwaay B, Cunha GC, Leibold E, Looser R, Mellert W, Prokoudine A, et al. The use of metabolomics for the discovery of new biomarkers of effect. Toxicol Lett 2007;172:21-8.
19. Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, Poitou C, Clement K. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Rouxen-Y gastric bypass surgery. PLoS One 2009;4:e7905.
20. Allaway D, Kamlage B, Gilham M, Hewson-Hughes A, Wiemer J, Colyer A, Rein D. Effects of dietary glucose supplementation on the fasted plasma metabolome in cats and dogs. Metabolomics 2013;9:1096-108.
21. Yamada H, Yamahara A, Yasuda S, Abe M, Oguri K, Fukushima S, Ikeda-Wada S. Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine. J Anal Toxicol 2002;26:17-22.
22. Masoodi M, Nicolaou A. Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 2006;20:3023-9.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995;57:289-300.
24. Brand T, Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 2011;57:1376-86.
25. Sanner JE, Frazier L, Udtha M. Effects of delayed laboratory processing on platelet serotonin levels. Biol Res Nurs 2013;15:13-6.
26. Yu Z, Kastenmueller G, He Y, Belcredi P, Moeller G, Prehn C, et al. Differences between human plasma and serum metabolite profiles. PLoS One 2011;6:e21230.
27. Holmsen H, Day HJ, Setkowsk CA. Secretory mechanisms. Behavior of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Biochem J 1972;129:67-82.
28. Haenel P, Andreani P, Graeler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 2007;21:1202-9.
29. Kattlove HE, Alexander B. Effect of cold on platelets. I. Cold-induced platelet aggregation. Blood 1971;38:39-48.
30. Kattlove HE, White F, Alexander B. Effect of cold on platelets. II. Platelet function after short-term storage at cold temperatures. Blood 1972;40:688-96.
31. Kattlove HE, Mormino D. Effect of cold on platelets. III. Adenine nucleotide metabolism after brief storage at cold temperature. Blood 1973;42:557-64.
32. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764-72.
33. Bathe OF, Shaykhutdinov R, Kopciuk K, Weljie AM, Mckay A, Sutherland FR, et al. Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol Biomarkers Prev 2011;20:140-7.
34. Sugiura T, Dohi Y, Yamashita S, Ohte N, Ito S, Iwaki S, et al. Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis. Coron Artery Dis 2012;23:234-8.
35. Hirowatari Y, Hara K, Shimura Y, Takahashi H. Serotonin levels in platelet-poor plasma and whole blood from healthy subjects: relationship with lipid markers and coronary heart disease risk score. J Atheroscler Thromb 2011;18:874-82.
36. Sun H, Zhang A, Yan G, Piao C, Li W, Sun C, et al. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 2013;12:710-9.
37. Pechlivanis A, Kostidis S, Saraslanidis P, Petridou A, Tsalis G, Veselkov K, et al. 1H NMR study on the short- and long-term impact of two training programs of sprint running on the metabolic fingerprint of human serum. J Proteome Res 2013;12:470-80.
38. Ghandforoush-Sattari M, Mashayekhi SO, Nemati M, Ayromlou H. Changes in plasma concentration of taurine in stroke. Neurosci Lett 2011;496:172-5.
39. Qi S, Ouyang X, Wang L, Peng W, Wen J, Dai Y. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy. Clin Transl Sci 2012;5:379-85.